Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001876745 | SCV002119072 | uncertain significance | Peroxisome biogenesis disorder, complementation group K | 2023-07-07 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 2 of the PEX14 protein (p.Ala2Leu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1356517). This variant has not been reported in the literature in individuals affected with PEX14-related conditions. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. |